Member access

4-Traders Homepage  >  Shares  >  Nasdaq  >  Vertex Pharmaceuticals Incorporated    VRTX   US92532F1003

SummaryQuotesChart AnalysisNewsCalendarCompanyFinancialsConsensusRevisionsForum 
Income Statement Evolution
Vertex Pharmaceuticals Inc : Income Statement Evolution
Annual Income Statement Data
Actuals in M $ Estimates in M $
Fiscal Period December 201020112012201320142015
Sales1431 4111 5271 2031 0151 733
Operating income (EBITDA)-666149174-326-229180
Operating profit (EBIT)-696114136-521-304255
Pre-Tax Profit (EBT)---12,4---
Net income-75529,6-107-369-308215
EPS ( $)-3,770,14-0,50-1,92-1,540,55
Dividend per Share ( $)------
Yield------
Announcement Date02/03/2011
09:01pm		02/02/2012
09:00pm		01/29/2013
09:01pm		---
Finances - Leverage
Vertex Pharmaceuticals Inc : Finances - Leverage
Actuals in M $ Estimates in M $
Fiscal Period December 201020112012201320142015
Debt------
Finance63196992132325859,5
Operating income (EBITDA)-666149174-326-229180
Leverage
(Debt/EBITDA)		------
Capital Expenditure38,134,671,136,849,158,8
Book Value Per Share (BVPS)2,48 $3,76 $4,60 $3,80 $2,51 $3,75 $
Cash Flow per Share-3,17 $0,69 $1,26 $-0,49 $-1,46 $0,73 $
Announcement Date02/03/2011
09:01pm		02/02/2012
09:00pm		01/29/2013
09:01pm		---
Balance Sheet Analysis
Vertex Pharmaceuticals Inc : Balance Sheet Analysis
Assessed data source :
© 2013 Thomson Reuters
Advertisement
Financial Ratios

Size 2013e 2014e
Capitalization 17 376 M$ -
Company Value 17 052 M$ 17 117 M$
Valuation 2013e 2014e
PER (Price / EPS)
Capitalization / Revenue 14,4x 17,1x
EV / Revenue 14,2x 16,9x
EV / EBITDA -52,4x -74,6x
Yield (DPS / Price) - -
Profitability 2013e 2014e
Operating Margin (EBIT / Sales) -43,3% -30,0%
operating laverage (Delta EBIT / Delta Sales) -22,8x -
Net Margin (Net Profit / Revenue) -30,6% -30,4%
ROA (Net Profit / Asset) -1,07% -12,5%
ROE (Net Profit / Equities) -21,6% -72,0%
Rate of Dividend - -
Balance Sheet Analysis 2013e 2014e
CAPEX / Sales   3,06% 4,84%
Cash Flow / Sales (Taux d'autofinancement) -9,02% -31,8%
Capital Intensity (Assets / Sales) 28,6x 2,43x
Financial Leverage (Net Debt / EBITDA) 0,99x 1,13x
Price Earning Ratio
Vertex Pharmaceuticals Inc : Price Earning Ratio
EPS & Dividend
Vertex Pharmaceuticals Inc : EPS Dividend
Dynamic quotes  
ON
| OFF
My Watchlist|My Portfolio
4-traders.com :
About :
Copyright © 2013 Surperformance. All rights reserved.